Sulphasalazine treatment in rheumatoid arthritis
Bax, D.E.; Greaves, M.S.; Amos, R.S.
Journal of Rheumatology 13(2): 463-464
1986
ISSN/ISBN: 0315-162X PMID: 2873249 Document Number: 274076
Document emailed within 1 workday
Related Documents
Pullar, T.; Hunter, J.A.; Capell, H.A. 1985: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy British Journal of Rheumatology 24(3): 269-276Islam, M.N.; Alam, M.N.; Haq, S.A.; Moyenuzzaman, M.; Patwary, M.I.; Rahman, M.H. 2000: Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis Bangladesh Medical Research Council Bulletin 26(1): 1-7
Keso, L.; Kaarela, K.; Oksanen, K.; Ahonen, M. 1998: Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy Duodecim; Laaketieteellinen Aikakauskirja 114(17): 1731-1733
Shenoy, P.; Misra, R.; Jain, M.; Agarwal, V. 2008: Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome New Zealand Medical Journal 121(1276): 102-105
Georgescu, C. 1992: Sulphasalazine therapy in rheumatoid arthritis. a two-year study and follow-up of clinical results Romanian Journal of Internal Medicine 30(2): 127-132
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153
Varbanova, B.B.; Dyankov, E.D. 1999: Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis Advances in Experimental Medicine and Biology 455: 331-336
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Rachwał-Siek, K.; Ponikowska, M.; Wiland, P. 2011: Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report Wiadomosci Lekarskie 64(4): 283-287